PREVENTION OF TYPE 2 DIABETES - PowerPoint PPT Presentation

1 / 18
About This Presentation
Title:

PREVENTION OF TYPE 2 DIABETES

Description:

45 years with FH, GDM, baby 9 lbs, dyslipidemia, hypertension, non-Caucasian ... Hypertension. PCOS. Dyslipidemia. Diabetes Prevention Program. For People ... – PowerPoint PPT presentation

Number of Views:280
Avg rating:3.0/5.0
Slides: 19
Provided by: CHLA9
Category:

less

Transcript and Presenter's Notes

Title: PREVENTION OF TYPE 2 DIABETES


1
PREVENTION OFTYPE 2 DIABETES
  • Francine Ratner Kaufman, M.D.
  • Professor of Pediatrics
  • The Keck School of Medicine of USC
  • Head, Center of Diabetes, Endocrinology and
    Metabolism
  • Childrens Hospital Los Angeles
  • President, American Diabetes Association

2
Burden of Diabetes in USA
  • 17 Million Americans Have Diabetes
  • 16 Million Americans Have Prediabetes
  • 210,000 Diabetes-Related Deaths/year
  • Leading Cause of Blindness, Kidney Failure,
    Amputation
  • 65 Cardiovascular Disease-Related Death
  • Cost 132 Billion/2002

Mokdad, et al, JAMA 2001 286,1195
3
Diabetes Prevalence Among Minority Populations in
the U.S.
Percentage of each population with diabetes
Non-Hispanic Whites
Latinos
African Americans
Native Americans Alaska Natives
7.8 (11.4 million)
10.2 (2 million)
13 (2.8 million)
15.1 (105,000)
?
Asian Americans and Pacific Islanders are 2-5
times more likely to have diabetes than
Non-Hispanic Whites.
Centers for Disease Control and Prevention (CDC)
1999 www.cdc.gov/diabetes

4
Natural History of Type 2 Diabetes
Onset ofdiabetes
Geneticsusceptibility Environmentalfactors Nutr
ition Obesity Physical inactivity
Complications
Disability
IGT
Ongoing hyperglycemia
Insulin resistance
Death
Hyperinsulinemia HDL-C TriglyceridesAtheroscl
erosisHypertension
BlindnessRenal failureCHDAmputation
RetinopathyNephropathyNeuropathy
AtherosclerosisHyperglycemiaHypertension
5
The Diabetes Prevention Program A Randomized
Clinical Trial to Prevent Type 2 Diabetes in
Persons at High Risk The DPP Research Group
6
Study Interventions
Eligible participants Randomized Standard
lifestyle recommendations
Intensive DRUG
Placebo Lifestyle Metformin (n 1079)
(n 1073) (n 1082)
7
Weight Change
Placebo
Metformin
Lifestyle
The DPP Research Group, NEJM 346393-403, 2002
8
Type 2 Diabetes Prevention
Percent developing diabetes

Risk reduction 31 by metformin 58 by lifestyle
All participants
All participants
Lifestyle (n1079, pPlac )
Metformin (n1073, p40
Placebo (n1082)
30
Placebo
Metformin
Cumulative incidence ()
20
Lifestyle
10
0
0

1

2

3

4
Years from randomization
The DPP Research Group, NEJM 346393-403, 2002
9
Prevention of Type 2 with Lifestyle Intervention
Tuomilehto, et al , Turku ADA 2000
  • Intervention 523 IGT, mean age 55, BMI 31
  • Diet, exercise, frequent visits vs advice yearly

Incidence of diabetes reduced 58 (p.0003)
10
DIABETES INCIDENCE IN PREVENTION STUDIES
11
  • Translation of the
  • DPP Results

12
ADA/NIDDK Screening Recommendations For
Prediabetes in AdultsDiabetes Care, 252002
  • Case Finding
  • Test
  • 45 years, BMI 25 kg/m2
  • 9 lbs,
    dyslipidemia, hypertension, non-Caucasian
  • At 3 yr intervals, if negative

13
ADA/NIDDK Recommendations In AdultsDiabetes
Care, 252002
  • How to Test
  • In context of health care visit
  • FPG, 2-h OGTT
  • Intervention
  • Prediabetes counsel for weight loss and PA,
    Follow-up counseling
  • Monitor for DM q 1-2 years, CVD risk factors
  • Avoid drug therapy

14
What Children Should be Tested ADA/AAP
RecommendationsDiabetes Care 232000
  • Age 10 years or onset of puberty
  • BMI 85th
  • First or Second Degree Relative
  • Race/Ethnic Group
  • Signs of Insulin Resistance
  • Acanthosis nigricans
  • Hypertension
  • PCOS
  • Dyslipidemia

15
Small Steps Big Rewards
Diabetes Prevention Program For People at High
Risk
  • Weight Loss
  • Diet
  • Exercise
  • Lower Risk for Diabetes

16
Studies to Treat Or Prevent Pediatric Type 2
Diabetes(STOPP-T2D)
Funded by National Institute of Diabetes and
Digestive and Kidney Diseases National Institutes
of Health
TODAY
17
Weight Loss Reduces Medical Costs
  • Costs of diabetes 132 billion (2002)
  • Direct Costs 5.7 National Health Expenditure
  • 7 10 Weight Loss
  • 58 Reduction in Diabetes
  • Treatment Cost Reduction
  • 123 for the insulin-treated patient/month
  • 61 for the hyperlipidemic patient/month

(Wolf AM, Colditz GA. Obes Res. 1998) (Greenway
FL, et al. Obes Res. 1999)
18
GLOBAL PROJECTIONS FOR THE DIABETES EPIDEMIC
2000-2010
26.5 32.9 24
14.2 17.5 23
84.5 132.3 57
9.4 14.1 50
1.0 1.3 33
15.6 22.5 44
World 2000 151 million 2010 221
million Increase 46
Write a Comment
User Comments (0)
About PowerShow.com